BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.71B |
| 2 |
Alibaba
BABA
|
+$2.19B |
| 3 |
Truist Financial
TFC
|
+$2.16B |
| 4 |
iShares MBS ETF
MBB
|
+$841M |
| 5 |
ServiceNow
NOW
|
+$829M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$5.15B |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$2.34B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$983M |
| 4 |
VIAB
Viacom Inc. Class B
VIAB
|
+$684M |
| 5 |
Apple
AAPL
|
+$623M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.19% |
| 2 | Financials | 14.42% |
| 3 | Healthcare | 13.59% |
| 4 | Consumer Discretionary | 9.97% |
| 5 | Industrials | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FLNT
3401
Fluent
FLNT
$120M
| $6.91M | ﹤0.01% |
460,706
-16,230
| -3% | -$219K |
|
3402
Acacia Research
ACTG
$470M
| $6.88M | ﹤0.01% |
2,586,101
-6,804
| -0.3% | -$18.7K |
|
|
MMAC
3403
DELISTED
MMA Capital Holdings, Inc. Common Stock
MMAC
| $6.87M | ﹤0.01% |
215,952
+5,485
| +3% | +$173K |
|
3404
LSI Industries
LYTS
$924M
| $6.84M | ﹤0.01% |
1,131,433
-50,076
| -4% | -$275K |
|
3405
Victory Capital Holdings
VCTR
$6.65B
| $6.84M | ﹤0.01% |
326,136
+47,637
| +17% | +$864K |
|
3406
iShares Inflation Hedged Corporate Bond ETF
LQDI
$69.7M
| $6.82M | ﹤0.01% |
255,000
-20,000
| -7% | -$530K |
|
3407
Union Bankshares
UNB
$109M
| $6.81M | ﹤0.01% |
187,832
+1,659
| +0.9% | +$56.5K |
|
3408
PUT
Sinclair Inc
SBGI
$1.03B
| $6.8M | ﹤0.01% |
+204,000
| New | +$7.6M |
|
|
EWJE
3409
DELISTED
iShares MSCI Japan Equal Weighted ETF
EWJE
| $6.8M | ﹤0.01% |
190,000
| – | – |
|
3410
Gaia
GAIA
$48.4M
| $6.79M | ﹤0.01% |
849,529
+444
| +0.1% | +$3.43K |
|
|
HARP
3411
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $6.76M | ﹤0.01% |
45,683
+13,484
| +42% | +$2.05M |
|
|
SCPL
3412
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
| $6.72M | ﹤0.01% |
546,549
+43,605
| +9% | +$463K |
|
|
SLY
3413
DELISTED
SPDR S&P 600 Small Cap ETF (based on S&P SmallCap 600 Index--symbol SML)
SLY
| $6.69M | ﹤0.01% |
92,344
-5,041
| -5% | -$350K |
|
3414
PUT
Teva Pharmaceuticals
TEVA
$41.2B
| $6.68M | ﹤0.01% |
681,500
+205,000
| +43% | +$1.83M |
|
3415
iShares International Equity Factor ETF
INTF
$3.75B
| $6.63M | ﹤0.01% |
245,184
-495,577
| -67% | -$13.1M |
|
3416
MidCap Financial Investment
MFIC
$804M
| $6.63M | ﹤0.01% |
379,679
+13,334
| +4% | +$220K |
|
3417
Airgain
AIRG
$72.4M
| $6.6M | ﹤0.01% |
617,630
+34,608
| +6% | +$363K |
|
3418
Franco-Nevada
FNV
$46B
| $6.6M | ﹤0.01% |
63,851
-17,693
| -22% | -$1.71M |
|
|
CFMS
3419
DELISTED
Conformis, Inc. Common Stock
CFMS
| $6.59M | ﹤0.01% |
175,619
+1,662
| +1% | +$78.8K |
|
|
ADMS
3420
DELISTED
Adamas Pharmaceuticals
ADMS
| $6.58M | ﹤0.01% |
1,735,309
-480,867
| -22% | -$2.3M |
|
3421
Oak Valley Bancorp
OVLY
$281M
| $6.54M | ﹤0.01% |
335,939
+3,493
| +1% | +$61.9K |
|
3422
Capital Bancorp
CBNK
$615M
| $6.53M | ﹤0.01% |
438,426
+5,061
| +1% | +$71.8K |
|
3423
Lineage Cell Therapeutics
LCTX
$278M
| $6.49M | ﹤0.01% |
7,291,981
+2,439
| +0% | +$2.03K |
|
|
YELL
3424
DELISTED
Yellow Corporation Common Stock
YELL
| $6.47M | ﹤0.01% |
2,539,058
+835
| +0% | +$2.86K |
|
|
RLH
3425
DELISTED
Red Lions Hotel Corporation
RLH
| $6.47M | ﹤0.01% |
1,733,567
+9,978
| +0.6% | +$46.6K |
|
Similar funds
BlackRock's Q4 2019 Portfolio in Review
As of Q4 2019, BlackRock held 5,193 positions worth $2.61T, up 9.5% from $2.38T the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BlackRock's Q4 2019 filing shows 167 new, 2,887 increased, 1,450 reduced and 161 closed positions. Its largest new stake was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 324,030 shares worth $382M. The largest sale was Celgene Corp, an estimated $5.15B.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- BlackRock's largest Q4 2019 buy was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 324,030 shares worth $382M.
- BlackRock added most to Bristol-Myers Squibb in Q4 2019, an estimated $2.71B increase.
- BlackRock's biggest Q4 2019 reduction was iShares Core S&P 500 ETF, cutting an estimated $983M.
- BlackRock fully exited Celgene Corp in Q4 2019, selling an estimated $5.15B.
- BlackRock's ten largest holdings make up 15% of its $2.61T portfolio in Q4 2019.
- BlackRock opened 167 new positions and closed 161 in Q4 2019.
- BlackRock's portfolio value rose 9.5% quarter-over-quarter to $2.61T.
Based on BlackRock's 13F filing for Q4 2019, filed 13 Feb 2020.